Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
06/1989
06/07/1989EP0318492A1 Pharmaceutical formulations comprising microcapsules
06/06/1989US4837378 Topical metronidazole formulations and therapeutic uses thereof
06/06/1989US4837255 Palatable hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
06/06/1989US4837213 Pharmaceutical vehicle for active substances in the form of an anhydrous gel
06/06/1989US4837211 Spironolactone composition
06/06/1989US4837029 Dimethyl polysiloxane, cationic or nonionic surfactant
06/06/1989US4837026 Transdermal and systemic preparation and method
06/06/1989US4837025 Self-adhesive device for the percutaneous administration of an active ingredient
06/06/1989US4837022 Composition containing tissue plasminogen activator
06/06/1989US4837017 Induces antibody formation in animals
06/06/1989US4836957 Using amino acid
06/06/1989CA1255229A1 Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
06/06/1989CA1255227A1 Method for production of stable nicorandil preparation
06/06/1989CA1255222A1 Pharmaceutical composition
06/01/1989WO1989004828A1 Cyclodextrin clathrates of 5-cyano-prostacycline derivatives and their use as drugs
06/01/1989WO1989004689A1 Glassy matrix for administration of beneficial agent
06/01/1989WO1989004673A1 Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
06/01/1989WO1989004672A1 Derivatives of lincosaminide antibiotics
06/01/1989WO1989004671A1 Differential delivery of therapeutic agents across the blood brain barrier
06/01/1989WO1989004648A1 Temperature-controlled active agent dispenser
05/1989
05/31/1989EP0318398A1 Diltiazem sustained release form and medicament thereof
05/31/1989EP0318246A2 Process and means to avoid absorption of harmful compounds
05/31/1989EP0318146A1 Antibiotic solutions and the lyophilization thereof
05/31/1989EP0318081A1 Stabilization of antibodies
05/31/1989EP0317957A2 Drug-monoclonal antibody conjugates
05/31/1989EP0317878A1 Stabilized pharmaceutical agents, process for preparing them, and stable pharmaceutical preparations
05/31/1989EP0317780A1 Sustained (controlled) release delivery system for substituted dihydropyridine calcium channel blockers
05/30/1989US4835248 Biologically degradable polyamide for depot preparations having controlled release of the active compound
05/30/1989US4835188 Spray dried ibuprofen
05/30/1989US4835149 Solubilization of salts of pyridine-2-thiol-1-oxide
05/30/1989US4835142 Powdery pharmaceutical composition suitable for application to mucosa of oral or nasal cavity
05/30/1989US4835138 Choline esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities
05/30/1989US4834985 Solid matric of water soluble polydextrose, cyclodextrin or cellulose ether and fatty alcohol or polyoxyalkylene glycol
05/30/1989US4834973 Immunological methods for treating mammals
05/30/1989US4834966 Pharmaceutical composition with analgesic activity
05/30/1989US4834734 Topical skin dressings
05/30/1989CA1254909A1 Dobutamine salts
05/30/1989CA1254832A1 Interferon administration vehicles
05/24/1989EP0317405A1 Ophthalmic solution comprising iodine-polyvinylpyrrolidone complex
05/24/1989EP0317281A2 Pharmaceutical formulations containing melphalan or melphalan hydrochloride, as well as melphalan and melphalan hydrochloride and processes for preparing them
05/24/1989EP0317274A1 Chewable medicament tablet containing means for taste masking
05/24/1989EP0317272A1 Flaky powder of zinc oxide and its composition for external use
05/24/1989EP0317180A1 Temperature-controlled active agent dispenser
05/24/1989EP0317120A1 Improved amphotericin B liposome preparation
05/24/1989EP0317105A2 Phenylalanine derivative and its uses
05/24/1989EP0316834A1 Steroid cream formulation
05/24/1989EP0316815A1 Steroid ointment formulation
05/23/1989US4832957 Controlled release combination of carbidopa/levodopa
05/23/1989US4832954 Nicorandil containing external preparations
05/23/1989US4832682 Injection method and apparatus with electrical blood absorbing stimulation
05/23/1989CA1254513A1 Sweetener delivery systems
05/23/1989CA1254512A1 Metal or earth alkali lanolate emulsifying system and water-in-oil type emulsions containing this system
05/23/1989CA1254510A1 Fibronectin preparations
05/18/1989WO1989004370A1 Human monoclonal anti-hiv-i-antibodies
05/18/1989WO1989004179A1 Pharmaceutical formulations for transdermal administration
05/18/1989WO1989004177A1 Gamma interferon formulation
05/17/1989EP0316212A1 Use of nitrophenyls or anti-nitrophenyl antibodies for modification of the interaction between host-sensitive cells and a pathogenic agent
05/17/1989EP0316174A1 Aqueous preparation of 9-methyl-3-(1H-tetrazol-5-yl)-4H-Pyrido[1,2-a]pyrimidin-4-one potassium salt
05/17/1989EP0315968A1 Plasma and recombinant protein formulations in low ionic strength media
05/17/1989EP0315964A1 A novel pharmaceutical composition comprising exifone and water-soluble polymer
05/16/1989US4831129 Directly compressible powdered maltitol and its process of preparation
05/16/1989US4831117 Monoclonal antibody specific for human B-cells
05/16/1989US4831061 Free radical polymerization of lactam and amide
05/16/1989US4831058 Therapeutic agents
05/16/1989US4831023 Water washable vehicles for topical use
05/16/1989US4831022 And cyclodextrin
05/16/1989US4830962 Expression vectors encoding for a dt-a fragment which use dna control sequences not native to the coding sequences but compatible to the host
05/16/1989US4830860 Stressed polymeric device for controlled release of a substance to an ambient environment
05/16/1989US4830859 Process for lubricating water-soluble vitamin powders
05/16/1989US4830856 Medical bandage comprising a membrane and a reservoir containing a chelating agent, dmso, a ph adjuster and water
05/16/1989US4830855 Temperature-controlled active agent dispenser
05/16/1989US4830853 Ascorbic acid, sodium ascorbate
05/16/1989US4830852 Covalent-modification and having a coupling spacer containing a thioether; vaccines; chemical stability; infant protection
05/16/1989US4830847 Radioactive proteins
05/16/1989CA1254143A1 Pharmaceutical preparation with a content of ibuprofen, and process for its preparation
05/10/1989EP0315349A1 Phospholipase A2 inhibiting compositions and their use
05/10/1989EP0315220A1 Method of forming a metal chelate protein conjugate
05/10/1989EP0315219A2 Pharmaceutical compositions
05/10/1989EP0315218A2 Pharmaceutical compositions
05/10/1989CN1032743A Somatotropin formulations
05/10/1989CN1032739A Pharmaceutical composition for piperidinoalkanol derivatives
05/10/1989CN1032738A Pharmaceutical composition for piperidinoalkanol-decongestant combination
05/09/1989USRE32919 Tissue-type plasminogen activator
05/09/1989US4829092 Synergistic
05/09/1989US4829088 Medicament for the treatment of inflammations of the eye
05/09/1989US4829083 2-amino-2-hydroxymethyl-1,3-propanediol or homolog
05/09/1989US4828836 Controlled release pharmaceutical composition
05/09/1989US4828831 New conjugates of vinblastine and its derivatives, process for preparing them and pharmaceutical compositions containing them
05/09/1989CA1253806A1 Physically modified beclomethasone dipropionate suitable for use in aerosols
05/05/1989WO1989003849A1 Oligonucleotide-polyamide conjugates
05/05/1989WO1989003690A1 Application of dinitro-trinitrophenyl and its derivatives or of anti-nitrophenyl antibodies to the modification of the interaction between the target cellules of a host and a pathogenic agent
05/05/1989WO1989003687A1 Composition and method for treating cancers characterized by over-expression of the c-fms proto-oncogene
05/05/1989WO1989003680A1 Conjugates between a drug and a nitrophenyl group and their pharmaceutical application
05/05/1989WO1989003674A1 Microspheres, way of producing said microspheres and the use thereof
05/05/1989WO1989003671A1 Sustained-release preparation
05/03/1989EP0314580A1 Use of nitrophenyl groups for stimulating the capability of incorporation of a drug into the sensitive cells of a host
05/03/1989EP0314421A1 Somatotropin formulations
05/03/1989EP0314387A1 Stabilized pergolide compositions
05/03/1989EP0314317A1 Adheson variants, nucleic acid encoding them and compositions comprising them
05/03/1989EP0314095A1 Plasma and recombinant protein formulation in high ionic strength media
1 ... 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 ... 1712